[go: up one dir, main page]

CL2009000230A1 - Nutritional or dietary supplement composition comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and diabetic retinopathy. - Google Patents

Nutritional or dietary supplement composition comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and diabetic retinopathy.

Info

Publication number
CL2009000230A1
CL2009000230A1 CL2009000230A CL2009000230A CL2009000230A1 CL 2009000230 A1 CL2009000230 A1 CL 2009000230A1 CL 2009000230 A CL2009000230 A CL 2009000230A CL 2009000230 A CL2009000230 A CL 2009000230A CL 2009000230 A1 CL2009000230 A1 CL 2009000230A1
Authority
CL
Chile
Prior art keywords
vitamin
lutein
omega
nutritional
age
Prior art date
Application number
CL2009000230A
Other languages
Spanish (es)
Inventor
Georg Ludwig Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39708779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009000230(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2009000230A1 publication Critical patent/CL2009000230A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/30Copper compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/315Zinc compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Composición de suplemento nutricional o dietético que comprende vitamina C, vitamina E, luteina, zinc, ácidos grasos omega 3 y cobre; método de fabricación; uso para el tratamiento y/o prevención de la degeneración macular relacionada con la edad y/o retinopatía diabética.Composition of a nutritional or dietary supplement comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and / or diabetic retinopathy.

CL2009000230A 2008-02-04 2009-02-03 Nutritional or dietary supplement composition comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and diabetic retinopathy. CL2009000230A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08151045 2008-02-04

Publications (1)

Publication Number Publication Date
CL2009000230A1 true CL2009000230A1 (en) 2009-08-14

Family

ID=39708779

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000230A CL2009000230A1 (en) 2008-02-04 2009-02-03 Nutritional or dietary supplement composition comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and diabetic retinopathy.

Country Status (5)

Country Link
AR (1) AR070405A1 (en)
CL (1) CL2009000230A1 (en)
PE (1) PE20091462A1 (en)
TW (1) TW201000027A (en)
WO (1) WO2009098186A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1393710B1 (en) * 2009-04-29 2012-05-08 Graal Srl OROBUCCAL COMPOSITIONS CONTAINING A MIXTURE OF LUTEIN AND ZEAXANTHIN.
JP2016508955A (en) * 2011-09-12 2016-03-24 ジョルジオ タソスGEORGIOU, Tassos Use of omega fatty acids for disease treatment
CN103211216A (en) * 2013-04-25 2013-07-24 福建永生活力生物工程有限公司 Health food with function of improving memory in aided manner and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
WO2005110375A1 (en) * 2004-05-08 2005-11-24 Paul Edward L Jr Nutritional supplement for treatment of ocular diseases
FR2883182B1 (en) * 2005-03-16 2008-02-15 Novartis Ag VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES
DE202005012984U1 (en) * 2005-08-17 2005-11-24 W & B Pharmamarken Gmbh Oral combination, useful in the treatment and/or prophylaxis of eye diseases e.g. glaucoma, comprises one or more dosage units comprising e.g. zinc oxide; highly purified fish oil; ascorbic acid and optionally carotenoid, cinnamon
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
BRPI0620210A2 (en) * 2005-12-20 2011-11-01 Alcon Res Ltd composition and processes for inhibiting the progression of macular degeneration and promoting healthy vision
DE202006014588U1 (en) * 2006-09-20 2006-12-14 Orthomol Pharmazeutische Vertriebs Gmbh Carotenoid containing product, preferably a balanced diet supplement, useful for age-related eye diseases, comprises vitamins, carotenoids, flavonoids, sulfur containing amino acids, zinc, selenium, chrome, taurine and omega-3-fatty acid

Also Published As

Publication number Publication date
WO2009098186A1 (en) 2009-08-13
TW201000027A (en) 2010-01-01
AR070405A1 (en) 2010-04-07
PE20091462A1 (en) 2009-10-23

Similar Documents

Publication Publication Date Title
AR060387A1 (en) FOOD SUPPLEMENTS AND THEIR USES
WO2007076416A3 (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
AR064332A1 (en) SUPPLEMENTARY NUTRITIONAL OR DIETETIC COMPOSITION THAT STRENGTHENS AND PROMOTES RETINAL HEALTH
WO2008028631A3 (en) Skin care composition
BRPI1013723A8 (en) FOOD COMPOSITION FOR RUMINANTS AND METHODS OF SUPPLEMENTING THE DIET OF A RUMINANT WITH LYSINE AND PRODUCING A FOOD COMPOSITION FOR RUMINANTS
BRPI1007782A2 (en) Concentrated creamy solids and dry compositions of an oil-in-water emulsion, method for their production and use thereof for the production of sensory-enhanced foods and nutrition physiology.
CL2008000735A1 (en) COMPOSITION THAT INCLUDES A PARTIALLY HYDROLYZED CEREAL PROTEIN; PROCESS FOR THE PRODUCTION OF SUCH COMPOSITION; USE OF SUCH COMPOSITION AS COMPONENT OF NUTRITIONAL SUPPLEMENTS, SPORTS DRINKS, DRINKS OR FOOD PRODUCTS; Y
ECSP11011139A (en) ANTIBODIES AGAINST 2 HUMAN ANGIOPOYETINE
ATE508642T1 (en) HYDROXYTYROSOL-REINFORCED OILS AND THEIR USE
WO2007114945A3 (en) Compositions and methods for enhancing the antioxidant status of animals
WO2007092509A3 (en) Dietary supplement composition for blood lipid health
GB201014340D0 (en) Nutritional supplement formulation comprising saffron and resveratrol
MX2016012625A (en) Effect of lipophilic nutrients on diabetic eye diseases.
CL2008001180A1 (en) An instant drinkable powder comprising a filling agent and / or sugar coated at least partially with 0.1-5% short chain oil of saturated fatty acids of saturated triglecerides c4-c14; capsule comprising drinkable powder; powder production method; kit comprising a drinkable powder.
WO2005065669A8 (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
WO2014111811A8 (en) Veterinary supplements
AR105237A1 (en) METHOD AND NUTRITIONAL COMPOSITIONS CONTAINING PHOSFATIDYLETHANOLAMINE, SPPHINGOMYELINE AND DOCOSAHEXAENOIC ACID
ECSP13012799A (en) USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS
MX2021009825A (en) NUTRITIONAL SUPPLEMENT.
CL2011003235A1 (en) Fish food containing at least one water-soluble antioxidant selected from the group hydroxycinnamic acids or hydrobenzoic acids, contains up to 40 mg of pigment per kilogram of food of at least one pigment selected from the group comprising astaxanthin or canthaxanthin.
MX2012007587A (en) NUTRITIONAL COMPOSITIONS THAT INCLUDE FRUIT LEAVES INCLUDING DOCOSAHEXAENOIC ACID.
CL2009000230A1 (en) Nutritional or dietary supplement composition comprising vitamin C, vitamin E, lutein, zinc, omega 3 fatty acids and copper; manufacturing method; use for the treatment and / or prevention of age-related macular degeneration and diabetic retinopathy.
UY28976A1 (en) USE OF TRISUSTITUTED BENZOPIRANONAS
WO2012025229A8 (en) Composition and method of manufacture
WO2009037398A3 (en) Foodstuff composition to improve digestibility of foodstuff lipids